Annual Shareholders Equity
$51.09 M
-$25.64 M-33.41%
December 31, 2022
Summary
- As of February 10, 2025, RVLP annual stockholders equity is $51.09 million, with the most recent change of -$25.64 million (-33.41%) on December 31, 2022.
- During the last 3 years, RVLP annual shareholders equity has fallen by -$63.62 million (-55.46%).
Performance
RVLP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$16.33 M
-$23.67 M-59.19%
June 30, 2023
Summary
- As of February 10, 2025, RVLP quarterly stockholders equity is $16.33 million, with the most recent change of -$23.67 million (-59.19%) on June 30, 2023.
- Over the past year, RVLP quarterly shareholders equity has dropped by -$42.19 million (-72.10%).
Performance
RVLP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RVLP Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.4% | -72.1% |
| 3 y3 years | -55.5% | -87.5% |
| 5 y5 years | -88.3% | -96.1% |
RVLP Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.4% | at low | -78.7% | at low |
| 5 y | 5-year | -55.5% | at low | -89.2% | at low |
| alltime | all time | -89.0% | at low | -96.3% | at low |
RVL Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $16.33 M(-59.2%) |
| Mar 2023 | - | $40.00 M(-21.7%) |
| Dec 2022 | $51.09 M(-33.4%) | $51.09 M(-25.5%) |
| Sep 2022 | - | $68.55 M(+17.2%) |
| Jun 2022 | - | $58.51 M(-15.8%) |
| Mar 2022 | - | $69.48 M(-9.4%) |
| Dec 2021 | $76.73 M(-18.2%) | $76.73 M(+40.2%) |
| Sep 2021 | - | $54.75 M(-20.0%) |
| Jun 2021 | - | $68.45 M(-19.7%) |
| Mar 2021 | - | $85.20 M(-9.2%) |
| Dec 2020 | $93.86 M | $93.86 M(-37.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $150.69 M(+15.1%) |
| Jun 2020 | - | $130.91 M(-8.9%) |
| Mar 2020 | - | $143.74 M(+25.3%) |
| Dec 2019 | $114.71 M(-70.1%) | $114.71 M(-19.0%) |
| Sep 2019 | - | $141.70 M(-45.1%) |
| Jun 2019 | - | $257.91 M(-32.3%) |
| Mar 2019 | - | $381.24 M(-0.7%) |
| Dec 2018 | $383.85 M(-11.9%) | $383.85 M(-7.6%) |
| Sep 2018 | - | $415.50 M(-1.0%) |
| Jun 2018 | - | $419.59 M(-3.7%) |
| Dec 2017 | $435.78 M(-6.3%) | $435.78 M |
| Dec 2016 | $465.21 M | - |
FAQ
- What is RVL Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual shareholders equity year-on-year change?
- What is RVL Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly shareholders equity year-on-year change?
What is RVL Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of RVLP is $51.09 M
What is the all time high annual shareholders equity for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual stockholders equity is $465.21 M
What is RVL Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, RVLP annual stockholders equity has changed by -$25.64 M (-33.41%)
What is RVL Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of RVLP is $16.33 M
What is the all time high quarterly shareholders equity for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly stockholders equity is $435.78 M
What is RVL Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, RVLP quarterly stockholders equity has changed by -$42.19 M (-72.10%)